The shift Whereas in the past the technical barriers to building new business software were high, recent developments in AI have now reduced these barriers enormously. AI writes, refactors and tests code at speed. A simple, fully custom-built application can now be built from scratch in weeks, not months or years, and at a fraction of the cost.
As uncertainty in the global economy increases, there is renewed focus on resilience. During Supply Chain Media’s Webinar Wednesday, Alfons Willemsen and Menno Rustenburg from Involvation explain how to create a resilient and robust supply chain. IBP, including scenario planning, plays a key role in this. ‘‘We now have the tools to continuously...
-1.jpg)
In our view, network design and resilience are increasingly converging. We believe that the traditional network design approach - typically conducted as a project once every five years - needs to evolve into a continuous process. Involvation will present this vision and approach at the first European Supply Chain Summit organized by Optilogic in...
In pharmaceutical supply chains, the instinct to look for the 'right solution' is deeply ingrained. When shortages occur, costs rise or service levels drop, organizations often respond by launching improvement initiatives, implementing new systems or redesigning processes. While this solution-driven mindset feels productive and reassuring, it can...
Pharmaceutical supply chains face a unique set of challenges: balancing increasing shelf life requirements, navigating complex global networks and ensuring continuous product availability. These challenges highlight the importance of effective planning, precise coordination and seamless collaboration across all parts of the value chain and...
Have you ever wondered why many supply chain training programs do not deliver tangible business results? The answer lies in the lack of tailoring the training specifically to your organization’s unique objectives, challenges and industry realities. Much like specialty pharmaceuticals designed for precise medical diagnoses, your supply chain...
How Can Supply Chain Drive Rapid Revenue Growth? At the invitation of Involvation, growth champions Rituals and Assa Abloy shared their perspectives on this question during the Involvation event “Supply Chain as a Growth Engine.” Rituals has laid the foundation for its future with a new data platform, while Assa Abloy has shifted its focus from...
Imagine harnessing the power of pharmaceutical supply chain serialization—unique identifiers tracking products end-to-end to prevent falsification and to provide optimal visibility and efficiency—and applying it directly to your supply chain training programs.
Imagine your supply chain training programs as carefully manufactured medicines. Just as pharmaceuticals depend on an Active Pharmaceutical Ingredient (API) to achieve their therapeutic effect, your training programs rely on an essential component we call the Active Transfer Ingredient (ATI). Without ATI, training efforts often fall short,...
In pharmaceutical supply chains, Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) are essential to ensure products reach end users safely, reliably and with high quality. Why should your approach to supply chain training be any different? It’s time to bring this rigor and consistency to your training through Good Training...